BACKGROUND: Significant variability and a lack of transparency exist in the reporting of anterior resection outcomes.
D uring the past few decades patients with rectal cancer have seen significant improvements in survival. Patients are going on to live with the sequelae of their treatments, and survivorship issues have been brought to the forefront of research. With the continued successes of neoadjuvant chemotherapy and radiation therapy, along with innovations in surgical stapling devices, colorectal surgeons are able to push the limits of the anterior resection (AR), with ultralow and even coloanal anastomoses. However, after an AR, up to 60% of patients experience some element of the AR syndrome, consisting of erratic defecatory patterns including incontinence, with significant effects on quality of life. [1] [2] [3] [4] Many factors contribute to a patient's ultimate functional outcome, but none have been studied more than the effect of radiation. Researchers have recently begun to focus on the prevalence of late intestinal toxicity following the 2 most common radiation regimens-preoperative short-course (25 Gy, 5Gy/fraction) and preoperative long-course (46 -50 Gy, 1.8 -2Gy/fraction) radiation. Controversy clearly exists regarding the best option and which patients will benefit; European guidelines 5 recommend short-course therapy, and the majority of North American guidelines 6 -8 recommend long-course therapy, and with different stage indications. Many institutions in North America offer both treatment options, often selecting patients for a particular radiation regimen based on clinical experience and judgment, but not based on evidence. Radiation regimen as a risk factor for late bowel dysfunction needs to clarified.
Presently, there is a large body of literature investigating rectal cancer surgery outcomes and prognostic factors. However, there is wide variability in the reporting of these risk factors and outcomes. Despite the availability of validated assessment tools, consistency and transparency in reporting are absent, confounding clinician assessments of the validity and accuracy of the reported results. Thus, the objectives of this review are 1) to qualitatively analyze the long-term functional outcomes and assessment tools used in evaluating patients with rectal cancer following AR, 2) to aggregate this large body of literature and quantify the incidence of late bowel dysfunction, and 3) to identify risk factors for long-term incontinence.
METHODS

Protocol
Study inclusion criteria, variables for data abstraction, and methods of analysis were specified a priori in the review protocol. (Protocol available on request from corresponding author.) The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist was used to help guide this report. 9
Eligibility Criteria
Reports of randomized trials, cohort studies, cross-sectional designs, and case series were included. Inclusion criteria were as follows: English language; adults with rectal cancer who underwent curative AR, excluding patients with metastatic or recurrent disease from the functional assessment; reporting of at least one bowel function outcome separate from any generic quality-of-life questionnaire; and a minimum of 1-year follow-up.
Information Sources and Search
An electronic literature search of MEDLINE (Ovid 1950 to June 2009, week 4), Embase (Ovid 1980 to June 2009, week 27), and CINAHL (1981 to June 2009) was conducted. The developed search strategies were peer-reviewed. Two reviewers (A.S., S.L.) independently reviewed all records by title and abstract followed by full-text articles for those meeting the screening criteria.
Data Collection Process and Items
Two reviewers (A.S., S.L.) independently abstracted data on study details (authors, year of publication, journal, funding sources, location), patient characteristics (age, sex, length of follow-up), function assessment tool used (validated, name of tool), outcomes (incontinence, urgency, frequency, nocturnal bowel movements, ability to differentiate gas from stool, clustering, incomplete evacuation, and pad usage) and possible risk factors for incontinence (radiation, previous vaginal deliveries, history of anorectal surgery, anastomotic height, and anastomosis type). The primary outcome of interest was incontinence to solid stool, liquid stool, or gas. Attempts were made to contact authors of all relevant studies to provide missing data.
Risk of Bias in Individual Studies
A single reviewer assessed risk of bias at the study level. The Cochrane Risk of Bias tool 10 was used for randomized trials, and the Downs-Black quality assessment tool 11 was used for nonrandomized studies. For nonrandomized studies, a score Ն17 of 31 was considered higher quality.
SUMMARY MEASURES AND SYNTHESIS OF RESULTS
Few studies presented their original data in a format amenable to meta-analysis. Articles that presented data as a median and range were converted to means according to Hozo et al. 12 A single weight-adjusted mean or proportion for each variable or outcome was computed for each of the nonrandomized studies. For the randomized trials, each arm that met the inclusion criteria was included in the meta-analysis as a separate study. To derive pooled estimates of proportions for the outcomes explored, random effects models were used. Pooling was conducted using Comprehensive Meta Analysis Version 2.2.046 (Englewood, NJ). A category of incontinence of any kind was included to capture studies that did not describe the type(s) of incontinence assessed. Furthermore, according to the Consensus Conference on Fecal Incontinence, fecal incontinence includes incontinence of solid stool, liquid stool, and gas because it results from the same physiology and is bothersome to patients. 13 For studies that provided information regarding the type of incontinence, the category with the highest rate of incontinence was included for this analysis. The individual categories were also pooled separately. For studies that included a scale measuring severity or frequency, any complaint other than never or none was included as a positive occurrence of incontinence. Given that this review assessed measures of prevalence, publication bias was not evaluated.
Additional Analyses
To explore the impact of possible prognostic factors on the rate of incontinence, exploratory meta-regressions were conducted by the use of logistic normal random effects models weighted by the inverse of the sum of the withintrial variances and the residual between-trial variances (using PROC NLMIXED) in SAS version 9.1 (SAS Inc, Cary, NC). Variables were identified a priori and were selected from those reported in the literature along with expert consultation. The following prognostic factors were considered at the study level: mean age of the patients, sex distribution, mean length of follow-up, the proportion of patients who received preoperative radiation (short-and long-course assessed together and separately), the proportion of patients who received postoperative radiation, anastomotic height classified as ultralow (Ͻ4 cm from the anal verge) and low (Ն4 cm), the proportion of patients with a straight anastomosis, and study quality. Univariate meta-regressions were computed for each prognostic factor. To generate best-fit lines in meta-regression graphs, an approximate correction was used to convert conditional means from the logistic normal model into marginal mean curves. 14 A sensitivity analysis was conducted to determine the effect of surgical time period on the rate of incontinence. Based on the popularization of the total mesorectal excision, studies with the majority of the study period preceding 1993 were analyzed separately from those with the majority of the study period after 1993.
RESULTS
Study Selection
From screening 805 records, 127 full-text articles were retrieved with 48 articles included in the systematic review and 43 in the meta-analysis ( Fig. 1 ). All included studies were considered representative of the typical adult patients undergoing curative rectal cancer resection.
Study Characteristics and Risk of Bias Assessment
The 48 included studies involved 3349 participants living in 17 countries with a median follow-up of 37.0 months Tables 1 and 2 . Two-thirds of studies (n ϭ 32) provided enough data to determine the number of patients lost to follow-up. On average, 6.6% (SD 7.4%) of patients were lost to follow-up, and 47.9% of studies had less than 10% loss to follow-up.
Results of Individual Studies and Synthesis of Results
The vast majority of studies used modified or newly developed questionnaires despite the availability of validated scoring systems to assess bowel function. The most commonly used validated scoring system was the Wexner scale 61 (19%) followed by the Kirwan scale 62 (8%). Four studies used published but nonvalidated questionnaires, and 65% used modified or newly developed questionnaires. In reporting, there were significant inconsistencies in the prognostic factors and outcomes described in the primary studies and in the definitions used to convey their severity. For example, only one study reported on patient obstetrical history or previous anorectal surgery. 51 Given the large between-study variability with wideranging heterogeneity (Fig. 2) , statistically pooled results should be interpreted with caution. However, these results are provided because they represent current best evidence for clinical care and guide sample-size calculations for future studies. At a minimum of 1-year follow-up, the pooled incidence of incontinence of any kind was 35.2% (95% CI 27.9, 43.3). The pooled incidence of solid fecal incontinence was 13.7% (95% CI 10.3, 18.0). Table 3 lists the reported range for each outcome and its pooled proportion. Figure 2 demonstrates the heterogeneity in re-ported outcomes, and the pooled proportions of incontinence, as well.
Meta-Regression
To explain the heterogeneity in the incidence of longterm incontinence reported at the primary study level, a number of variables were analyzed for an association with higher incidences of incontinence. Given the relatively lower number of studies and patients that reported solid fecal incontinence, no associations were detected between the variables and this outcome. Table 4 demonstrates the various prognostic factors and their associations with the different types of incontinence (univariate analysis). With the use of incontinence of any kind as the outcome, there was a significant association between preoperative radiation and higher incidences of incontinence (P ϭ .009), but no association between postoperative radiation and longterm incontinence (P ϭ .60). Short-course radiation therapy (SCRT), but not long-course radiation therapy (LCRT), was significantly associated with higher rates of long-term incontinence (P ϭ .006 and P ϭ .56). Similarly, SCRT was a risk factor for liquid and gas incontinence (P ϭ First year of study recruitment
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Incontinence-Unspecified FIGURE 2. Meta-analysis of reported incidence rates of incontinence. DISEASES OF THE COLON & RECTUM VOLUME 54: 12 (2011) .03). Ten studies evaluating SCRT in 692 patients and 8 studies evaluating LCRT in 604 patients were included in this analysis. There was no significant difference in mean follow-up between these studies with 57 months in the SCRT studies vs 44 months in the LCRT studies (P ϭ .58). Study design, randomized vs observational, was not associated with different rates of incontinence (P ϭ .31). However, within each study type, higher-quality studies were associated with higher reported rates of incontinence (randomized controlled trial P ϭ .004, observational P ϭ .006).
A sensitivity analysis was conducted to determine the impact of study time period on the rate of incontinence. With the use of a cutoff of 1993, based on the sentinel articles on total mesorectal excision by MacFarlane and colleagues, 63 no difference in incontinence was detected between the studies with surgeries conducted before 1993 and those with surgeries conducted after 1993 (P ϭ .55).
DISCUSSION
SUMMARY OF EVIDENCE
To the best of our knowledge this is the first systematic review of the long-term bowel function outcomes following AR for rectal cancer. We observed variability and lack of consistency in reporting risk factors and outcomes, and the heterogeneity in the functional results, as well. Despite the availability of validated assessment tools, researchers continue to develop their own methods, diluting the quality of rectal cancer research. Inadequately reported research has been shown to bias the estimates of effectiveness, offering some explanation for the variability in outcomes seen here. 64 Data from this review reported a significant rate of incontinence following AR and the substantial rates for various other sequelae such as urgency, the routine use of pads, and increased bowel movement frequency. These outcomes have negative effects on qual-ity of life and are consistent with the results of a recent Cochrane review. 65 AR syndrome following rectal cancer treatment is a spectrum of morbidity as seen clearly by the broad ranges of incidences reported. Although many risk factors for poorer bowel dysfunction have been postulated, this review highlights the major risk factor of preoperative radiation treatment and, in particular, SCRT. Given the relatively lower number of studies that reported high proportions of patients receiving either long-course preoperative radiation or postoperative radiation, along with the outcome of incontinence, it is difficult to draw meaningful conclusions for these risk factors. A recent review highlighted the discordant rates of late bowel dysfunction between patients undergoing SCRT vs LCRT. 66 With median follow-ups of 80, 61, and 180 months, the Swedish Rectal Cancer Trial, 2 Dutch Trial, 1 and Stockholm I and II 19 trials reported rates of long-term fecal incontinence of 62%, 65%, and 57% following SCRT. The European Organisation for Research and Treatment of Cancer (EORTC) 22921 trial, evaluating LCRT, reported a much lower incidence of fecal incontinence, 9%, after a median of 65 months. 67 The only completed trial to date evaluating SCRT vs LCRT was not powered to detect any differences in long-term toxicity. 68 However, after a median of 48 months, the relative risk of severe late toxicity, including bowel dysfunction for SCRT, was 1.49 (95% CI 0.67, 3.07). The Berlin Rectal Cancer Trial, 69 Stockholm III trial, 70 and The Australian GI Trials Group TROG 01.04 71 are currently evaluating these 2 treatments head-to-head to clarify the disparity in long-term toxicity. A review of current practice guidelines in North America and Europe highlights the need for clarification. In the United States, the National Comprehensive Cancer Network recommends LCRT for patients with stage II and III disease. 6 The European Society for Medical Oncology recommends that patients with early stage II disease undergo surgery alone, and patients with late stage II and all stage III disease receive SCRT. 5 The Canadian recommendations exemplify the confusion with some provinces recommending LCRT for stage II and III disease and others recommending SCRT for the same. 7, 8 This systematic review included studies over a long time period to capture long-term follow-up with accurate prevalence rates; however, the minority of studies (11/48) included patients with surgeries done before 1990. Differences in surgical technique over time (creation of a reservoir, total mesorectal excision) and radiation protocol (adjuvant vs neoadjuvant) exist. We attempted to control for the "time" in the meta-regression. In addition, the sensitivity analysis did not demonstrate any difference in incontinence rate between studies conducted before or in the "TME era." This review draws attention to a serious need for better risk factor assessment, including questioning patients about their obstetrical history and previous anorectal surgery. Moreover, the lack of consistency in reporting anastomosis type and height along with the heterogeneity in the way anastomosis height was reported decreased the ability of this review to detect a significant association. Future studies should provide a mean tumor/ anastomosis height and avoid reporting "low" or "high" or ϽX cm vs ՆX cm. Last, study quality for both randomized and observational studies was a significant predictor of incontinence. This highlights the sensitive nature of these outcomes and that rigorous methodology is required to elicit these outcomes from patients accurately and reliably.
Limitations
This review has a number of limitations. First, the included studies constitute a heterogeneous body of evidence with different methodologies and outcome definitions. The studies were designed with different primary outcomes, some bowel function, others not. In addition, the method of reporting, including reporting of frequencies of events, was variable, making data aggregation challenging. Furthermore, the time point of analysis differed among studies; however, all were at least one year after surgery. Conclusions drawn from this review need to be interpreted cautiously. The results represent current best evidence for clinical care and guide methodological considerations for future studies. Second, the meta-regression was limited by the covariates included in the primary studies, and thus only a univariate meta-regression was possible. Third, relationships between prognostic factors and incontinence are observational associations that can only generate hypotheses and stimulate future research. Finally, metaregression results are subject to an aggregation bias-such that relationships of patient data averaged across studies may not be the same as the relationships for individual patients within each study.
CONCLUSIONS
Anterior resection for rectal cancer is associated with significant long-term bowel dysfunction. Different definitions of reported outcomes and their severity complicate the interpretation and utility of results from many of the primary studies as well as the pooled results from this review. Uniformly adopted definitions and the use of validated assessment tools is required to improve our understanding of the outcomes following rectal resection in addition to risk factors for these outcomes. Preoperative radiation is a significant risk factor for late incontinence. Further trials may help to clarify the risk of late toxicity between short-course and long-course radiation.
